US 8377637
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P
granted A61PA61P35/00
Quick answer
US patent 8377637 (MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P35/00